by Angela C. H. McDonald | Aug 30, 2012
If you tuned into the evening news on Monday night (at least here in Canada), you would have seen my PhD supervisor Janet Rossant, discussing a recent advancement in stem cell differentiation. Amy Wong, post-doctoral fellow in the Rossant lab, created a protocol for...
by Lisa Willemse | Apr 24, 2012
An interview with Till & McCulloch Award winner, Dr. Aaron Schimmer, whose paper, entitled “Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia,” published in Cancer Cell, November 2011, was selected by committee as...
by Lisa Willemse | Feb 10, 2012
One of the advantages of working in an admin office of an organization that funds stem cell research is that you tend to hear about what’s happening in labs all across the country. So when I heard that some interesting things were happening in the Guy Sauvageau...
by Paul Krzyzanowski | Jan 24, 2012
Repurposing known drugs for new applications is a strategy with fascinating potential, with two of the most notable examples being Thalidomide and Viagra. Thalidomide was commonly used in the late 1950s as a sedative in pregnant women, later being associated with...
Comments